Concepedia

Publication | Open Access

A Phase I Study of the Pan Bcl-2 Family Inhibitor Obatoclax Mesylate in Patients with Advanced Hematologic Malignancies

DOIFull Paper Access

186

Citations

21

References

2008

Year

Aaron D. Schimmer, Susan O’Brien, Hagop M. Kantarjian, Joseph Brandwein, Bruce D. Cheson, Mark D. Minden, Karen Yee, Farhad Ravandi, Francis J. Giles, Andre C. Schuh,
Clinical Cancer Research

Abstract

Obatoclax mesylate is well tolerated and these results support its further investigation in patients with leukemia and myelodysplasia.

References

YearCitations

Page 1